Immediate Impact
1 by Nobel laureates 2 from Science/Nature 64 standout
Citing Papers
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
2024 Standout
Endocytosis in cancer and cancer therapy
2023 Standout
Works of Marta Climent being referenced
Objective response rate in a phase II multicenter trial of pertuzumab (P), a HER2 dimerization inhibiting monoclonal antibody, in combination with trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC) which has progressed during treatment with T
2007
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer
1995
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marta Climent | 144 | 83 | 61 | 11 | 219 | |
| Sabine Balmer Majno | 84 | 99 | 67 | 12 | 292 | |
| Rebeca Mondéjar | 133 | 91 | 32 | 16 | 228 | |
| Wafaa Elatre | 84 | 111 | 37 | 12 | 200 | |
| Hun Jung | 160 | 122 | 58 | 11 | 286 | |
| Josephine Stewart | 141 | 81 | 115 | 16 | 274 | |
| Fiona Langlands | 89 | 53 | 63 | 11 | 244 | |
| Ka Su | 69 | 75 | 80 | 9 | 249 | |
| Hazel Lote | 110 | 77 | 35 | 17 | 186 | |
| April Fritz | 131 | 53 | 55 | 7 | 222 | |
| Lawrence Kashat | 162 | 26 | 61 | 16 | 298 |
All Works
Loading papers...